Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tentin versus magistral dexamphetamine PK/PD crossover trial in adults with ADHD
NL-OMON53816Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dextroamphetamine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Objective effects on behavior/performance, Dexamphetamine plasma concentration and 1 more. Started Jun 2023; status: terminated.
02
Drugs
dextroamphetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON53816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53816.